THE RELATIONSHIP BETWEEN METABOLIC DISORDERS AND TUMOR PROGRESSION: REVIEW OF PRESENT DATA AND NEW THERAPEUTIC TARGETS

QR Code

THE RELATIONSHIP BETWEEN METABOLIC DISORDERS AND TUMOR PROGRESSION: REVIEW OF PRESENT DATA AND NEW THERAPEUTIC TARGETS

Background. Type 2 diabetes mellitus, obstructive sleep apnea, osteoarthritis and certain types of cancer are known to correlate with obesity. The mechanisms underlying the link between metabolic disorders and cancer remain obscure, yet assuming a potentially important role of reduced insulin sensit...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Semina, N. V. Danilova, N. A. Oleinikova, M. A. Agapov, K. A. Rubina
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2021-08-01
Series:	Сибирский онкологический журнал
Subjects:	metabolic syndrome obesity insulin insulin resistance adiponectin and t-cadherin the receptor for urokinase
Online Access:	https://www.siboncoj.ru/jour/article/view/1875
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy
by: K. A. Rubina, et al.
Published: (2021-05-01)

Adiponectin and insulin: molecular mechanisms of metabolic disorders
by: E. G. Uchasova, et al.
Published: (2020-10-01)

Clinical Features and Insulin Resistance in Men with a Metabolically Unhealthy Obesity Phenotype
by: E. I. Panova, et al.
Published: (2020-07-01)

METABOLIC EFFECTS OF ADIPONECTINE
by: E. V. Mitroshina, et al.
Published: (2014-12-01)

Topical insulin improves postoperative wound healing in controlled diabetic patients through regulating the expression of E-Cadherin and Ki67: an open-label randomized controlled-trial
by: Mahmoud Ahmed Khattab, et al.
Published: (2025-06-01)

Leptin and Adiponectin Levels in Patients with Chronic Hepatitis C with Carbohydrate and Lipid Metabolism Disorders
by: T. V. Antonova, et al.
Published: (2014-10-01)

The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis
by: S. A. Smetnev, et al.
Published: (2015-11-01)

Levels of Adipokines in Blood of Woman with Threatened Abortion
by: A. V. Shestopalov, et al.
Published: (2012-09-01)

Unlocking amyotrophic lateral sclerosis: the role of adiponectin in inflammation and disease progression
by: Mei Tian, et al.
Published: (2025-07-01)

Involvement of Urokinase-Type Plasminogen Activator Receptor in the Formation of a Profibrotic Microenvironment in the Epicardial Region
by: K. V. Dergilev, et al.
Published: (2021-12-01)

The Effects of Adipose Tissue Dysregulation on Type 2 Diabetes Mellitus
by: Jamie Rausch, et al.
Published: (2025-07-01)

PATHOGENETIC ASPECTS OF METABOLIC SYNDROME IN WOMEN OF REPRODUCTIVE AGE (A LITERATURE REVIEW)
by: Nina D. Kastueva, et al.
Published: (2019-05-01)

Blockade of the interleukin-6 signaling pathway in rheumatoid arthritis: Effects on obesity, adipocytokines and glucose metabolism
by: L. V. Kondratyeva, et al.
Published: (2024-01-01)

Role of Urokinase-Type Plasminogen Activator Receptor in the Regulation of Angiogenic Properties of Sca1+ Vasculogenic Progenitor Cells
by: К. V. Dergilev, et al.
Published: (2022-04-01)

Patients with arterial hypertension and obesity: targeting biomarkers as a personalised therapeutic approach
by: T. E. Morozova, et al.
Published: (2013-06-01)

Features and relationships of metabolic syndrome components in men with androgen deficiency. Part 2. Disorders of carbohydrate and purine metabolism. Retrospective study data
by: Z. Sh. Pavlova, et al.
Published: (2022-01-01)

INSULIN AND INSULIN RESISTANCE: NEW MOLECULE MARKERS AND TARGET MOLECULE FOR THE DIAGNOSIS AND THERAPY OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
by: A. B. Salmina, et al.
Published: (2013-10-01)

Adhesion molecules and cell-cytokine complex in vascular remodeling among patients with arterial hypertension and metabolic risk factors
by: L. R. Iskandarova, et al.
Published: (2008-10-01)

COMPARATIVE STUDY OF INTERACTION OF SOME DOMESTIC HUMAN INSULIN SUBSTANCES AND ITS ANALOGUES WITH INSULIN RECEPTOR BY METHOD OF SURFACE PLASMON RESONANCE
by: I. N. Urakova, et al.
Published: (2019-01-01)

Interaction of high-molecular-weight adiponectin concentration in blood serum with the risk of metabolic syndrome in women
by: O. D. Belyaeva, et al.
Published: (2021-10-01)

Lipotoxicity and metabolic disorders at obesity
by: V. T. Ivashkin, et al.
Published: (2010-02-01)

Human-relevant doses of bisphenol a induce insulin resistance by downregulating Irs1 expression in skeletal muscle through estrogen receptor-α
by: Zhang-Hong Ke, et al.
Published: (2025-09-01)

Research hotspots and trends in obesity and insulin resistance: A bibliometric analysis
by: Hui-xin Yan, et al.
Published: (2025-07-01)

Indicators of the fibrinolytic system in the blood and cerebrospinal fluid of patients with metastatic brain lesions
by: L. A. Goroshinskaya, et al.
Published: (2025-03-01)

Metabolic profile correction in patients with type 2 diabetes mellitus, suffering from obesity, with antidiabetic drug with active component based on the antibodies to C-terminal fragment of the β-subunit of the insulin receptor
by: N. V. Rogova, et al.
Published: (2021-06-01)

Prognostic value of the Metabolic Score for Insulin Resistance in the development of myocardial infarction in patients with coronary artery disease and obesity after coronary stenting
by: A. V. Svarovskaya, et al.
Published: (2022-11-01)

CORRECTION OF RISK FACTORS IN OVERWEIGHT PATIENTS WITH ARTERIAL HYPERTENSION
by: A. M. Shilov, et al.
Published: (2010-06-01)

IMMUNOLOGICAL FEATURES OF OBESITY AND THEIR INTERRELATION WITH VIOLATIONS OF A CARBOHYDRATE AND FATTY EXCHANGES
by: A. F. Salikhova, et al.
Published: (2014-07-01)

SOME FEATURES OF CYTOKINE PROFILE IN PATIENTS WITH GOUT AND INSULIN RESISTANCE SYNDROME
by: N. N. Kushnarenko, et al.
Published: (2014-07-01)

Adipocytokines in early rheumatoid arthritis: relationship to pro- and anti-inflammatory markers
by: L. V. Kondratyeva, et al.
Published: (2019-01-01)

Impact of Pathological Grades of Metabolic Dysfunction-Associated Steatotic Liver Disease on Weight Loss Following Laparoscopic Sleeve Gastrectomy
by: Qu YF, et al.
Published: (2025-07-01)

OPPORTUNITIES FOR THE USE OF VISCERAL OBESITY INDEX IN METABOLIC SYNDROME DIAGNOSTICS AND PROGNOSIS OF ITS COMPLICATION RISK
by: R. A. Libis, et al.
Published: (2014-09-01)

Bioactive camel milk peptides as regulators of insulin receptor signaling: Experimental and computational perspectives
by: Issoufou Katambe Mohamed, et al.
Published: (2025-07-01)

Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain
by: E. M. Frantsiyants, et al.
Published: (2022-03-01)

A RESISTANCE TO LEPTIN IN DEVELOPMENT OF DIFFERENT OBESITY PHENOTYPES
by: A. V. Ott, et al.
Published: (2016-04-01)

Optimizing antihypertensive therapy in postmenopausal women with metabolic syndrome
by: O. N. Poryvkina, et al.
Published: (2009-06-01)

Chromatographic and massspectrometric analysis of glycosylated recombinant human insulin.
by: M. N. Korchaznikova, et al.
Published: (2009-10-01)

EXPRESSION OF IGFBP-6 IN COLORECTAL CANCER: THE RELATION WITH INSULIN-LIKE GROWTH FACTOR RECEPTOR, ADIPONECTIN LEVEL AND ITS RECEPTORS
by: N. V. Yunusova, et al.
Published: (2015-12-01)

Insulin resistance contribution to pathogenesis of cardiac remodeling in patients with hypertension in combination with obesity and type 2 diabetes
by: M. E. Statsenko, et al.
Published: (2020-05-01)

The Interplay Between Body Weight and the Onset of Puberty
by: Alexandros K. Kythreotis, et al.
Published: (2025-05-01)